fatnews.com Home page  >  Article | Previous article | Next article

SEARCH

QUICKLINKS AND VIEW OPITONS

  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Follow @fatnews

    Drug trials are done to benefit the drug industry notes John Ioannidis


    Posted by .(JavaScript must be enabled to view this email address)
    Wednesday, December 14, 2016 9:35 am Email this article

    “Influential randomized [drug] trials are largely done by and for the benefit of the [drug] industry,” notes John Ioannidis from Stanford University.

    Meaning that they are not done to find scientific truth, but are simply done to sell more drugs.

    Later he continues on this topic by saying, “It is just that they often ask the wrong questions with the wrong short-term surrogate outcomes, the wrong analyses, the wrong criteria for success… , and the wrong inferences, but who cares about these minor glitches?”

    Reference

    Ioannidis JP. Evidence-based medicine has been hijacked: a report to David Sackett. J Clin Epidemiol, 2016 Mar 2; http://www.jclinepi.com/article/S0895-4356(16)00147-5/fulltext.

    Author’s Contact Info

    John Ioannidis
    Professor of Medicine and of Health Research and Policy
    Stanford University School of Medicine
    Professor of Statistics
    Stanford University School of Humanities and Sciences
    1265 Welch Rd, MSOB X306
    Stanford, CA 94305, USA
    .(JavaScript must be enabled to view this email address)

    Articles on the same subject can be found here:


    COMMENTS

    Please feel free to share your comments about this article.


    Name:

    Email:

    Comments:

    Please enter the word you see in the image below:


    Remember my personal information

    Notify me of follow-up comments?



    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.